Sandra J. Beaver

1.9k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Sandra J. Beaver is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra J. Beaver has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra J. Beaver's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (10 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Sandra J. Beaver is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (10 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Sandra J. Beaver collaborates with scholars based in United States. Sandra J. Beaver's co-authors include Nicholas F. LaRusso, Russell H. Wiesner, Jürgen Ludwig, Robert L. MacCarty, Roger R. Dozois, Ellen B. Hunter, Lloyd D. Fisher, Russell H. Wiesner, Patricia M. Grambsch and Thomas R. Fleming and has published in prestigious journals such as Gastroenterology, Hepatology and Mayo Clinic Proceedings.

In The Last Decade

Sandra J. Beaver

15 papers receiving 1.3k citations

Hit Papers

Primary sclerosing cholangitis: Natural history, prognost... 1989 2026 2001 2013 1989 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra J. Beaver United States 13 1.1k 695 689 499 150 15 1.4k
Maureen M. J. Guichelaar United States 12 538 0.5× 398 0.6× 447 0.6× 123 0.2× 19 0.1× 15 878
Mark Farrant United Kingdom 8 560 0.5× 383 0.6× 292 0.4× 168 0.3× 105 0.7× 12 742
Takeshi Kuyama Japan 9 114 0.1× 123 0.2× 265 0.4× 233 0.5× 48 0.3× 36 768
C Gouillat France 21 294 0.3× 302 0.4× 889 1.3× 290 0.6× 16 0.1× 67 1.3k
R Schöfl Austria 17 156 0.1× 237 0.3× 539 0.8× 402 0.8× 87 0.6× 56 822
Gaetano Vetrone Italy 19 957 0.9× 491 0.7× 929 1.3× 336 0.7× 11 0.1× 37 1.5k
M. E. Schwartz United States 17 945 0.9× 514 0.7× 758 1.1× 67 0.1× 16 0.1× 29 1.3k
Takahisa Fujikawa Japan 15 346 0.3× 136 0.2× 588 0.9× 204 0.4× 75 0.5× 100 1.0k
Karin Nachbaur Austria 14 782 0.7× 484 0.7× 538 0.8× 157 0.3× 6 0.0× 17 1.1k
Koichi Urata Japan 15 1.1k 1.0× 376 0.5× 1.1k 1.6× 78 0.2× 15 0.1× 33 1.3k

Countries citing papers authored by Sandra J. Beaver

Since Specialization
Citations

This map shows the geographic impact of Sandra J. Beaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Beaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Beaver more than expected).

Fields of papers citing papers by Sandra J. Beaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra J. Beaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Beaver. The network helps show where Sandra J. Beaver may publish in the future.

Co-authorship network of co-authors of Sandra J. Beaver

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra J. Beaver. A scholar is included among the top collaborators of Sandra J. Beaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra J. Beaver. Sandra J. Beaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Porayko, Michael K., Stephen C. Textor, Ruud A. F. Krom, et al.. (1994). Nephrotoxic Effects of Primary Immunosuppression With FK-506 and Cyclosporine Regimens After Liver Transplantation. Mayo Clinic Proceedings. 69(2). 105–111. 90 indexed citations
2.
Porayko, Michael K., Stephen C. Textor, R. A. F. Krom, et al.. (1993). Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.. PubMed. 25(1 Pt 1). 665–8. 9 indexed citations
3.
Lindor, Keith D., et al.. (1991). The combination of prednisone and colchicine in patients with primary sclerosing cholangitis.. PubMed. 86(1). 57–61. 94 indexed citations
4.
Porayko, Michael K., Russell H. Wiesner, J. Eileen Hay, et al.. (1991). Bone disease in liver transplant recipients: incidence, timing, and risk factors.. PubMed. 23(1 Pt 2). 1462–5. 140 indexed citations
5.
Wang, Kenneth K., Albert J. Czaja, Sandra J. Beaver, & Vay Liang W. Go. (1989). Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Hepatology. 10(1). 39–43. 49 indexed citations
6.
Wiesner, Russell H., Patricia M. Grambsch, E. Rolland Dickson, et al.. (1989). Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology. 10(4). 430–436. 479 indexed citations breakdown →
7.
Cangemi, John R., Russell H. Wiesner, Sandra J. Beaver, et al.. (1989). Effect of Proctocolectomy for Chronic Ulcerative Colitis on the Natural History of Primary Sclerosing Cholangitis. Gastroenterology. 96(2). 790–794. 55 indexed citations
8.
Cangemi, John R., Russell H. Wiesner, Sandra J. Beaver, et al.. (1989). Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology. 96(3). 790–794. 38 indexed citations
9.
Cangemi, John R., Sandra J. Beaver, Jürgen Ludwig, et al.. (1989). Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.. PubMed. 96(3). 790–4. 102 indexed citations
10.
LaRusso, Nicholas F., Russell H. Wiesner, Jürgen Ludwig, et al.. (1988). Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology. 95(4). 1036–1042. 128 indexed citations
11.
Czaja, Albert J., Sandra J. Beaver, James R. Wood, George G. Klee, & Vay Liang W. Go. (1987). Frequency and significance of serum α-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology. 93(4). 687–692. 12 indexed citations
12.
Quigley, Eamonn M.M., Sandra J. Beaver, R H Wiesner, & N. F. LaRusso. (1987). Familial occurrence of liver disease and inflammatory bowel disease in primary sclerosing cholangitis. 2. 1585. 3 indexed citations
13.
Lindor, Keith D., Russell H. Wiesner, Jerry A. Katzmann, Nicholas F. LaRusso, & Sandra J. Beaver. (1987). Lymphocyte subsets in primary sclerosing cholangitis. Digestive Diseases and Sciences. 32(7). 720–725. 47 indexed citations
14.
Wood, James R., Albert J. Czaja, Sandra J. Beaver, et al.. (1986). Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology. 6(5). 976–980. 24 indexed citations
15.
Wiesner, Russell H., Nicholas F. LaRusso, Roger R. Dozois, & Sandra J. Beaver. (1986). Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology. 90(2). 316–322. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026